These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3159215)

  • 21. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin, heparin fractions, and the atherosclerotic process.
    Engelberg H
    Semin Thromb Hemost; 1985 Jan; 11(1):48-55. PubMed ID: 3883499
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.
    Hollander W; Kirkpatrick B; Paddock J; Colombo M; Nagraj S; Prusty S
    Exp Mol Pathol; 1979 Feb; 30(1):55-73. PubMed ID: 217724
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
    Bourassa MG; Fisher LD; Campeau L; Gillespie MJ; McConney M; Lespérance J
    Circulation; 1985 Dec; 72(6 Pt 2):V71-8. PubMed ID: 3905060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
    Moor E; Hamsten A; Blombäck M; Herzfeld I; Wiman B; Rydén L
    Thromb Haemost; 1994 Sep; 72(3):335-42. PubMed ID: 7531874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery.
    Manchio JV; Gu J; Romar L; Brown J; Gammie J; Pierson RN; Griffith B; Poston RS
    Ann Thorac Surg; 2005 Jun; 79(6):1991-8. PubMed ID: 15919298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Saphenous vein to saphenous vein bypass grafting in four redo CABG patients].
    Ishitoya H; Endo M; Nishida H; Nakano K; Yagi Y; Koyanagi T; Abe R; Yamaki F; Hirota J; Nakatani H
    Kyobu Geka; 1995 Feb; 48(2):100-5. PubMed ID: 7897875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
    Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
    Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
    Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent progress in atherosclerosis research; experimental and clinical aspects.
    Clopath P; Dicato MA
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):21-33. PubMed ID: 359186
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of endothelium in the pathogenesis of vascular diseases.
    Hladovec J
    Cor Vasa; 1989; 31(6):433-43. PubMed ID: 2700153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors.
    Fuster V; Chesebro JJ
    Circulation; 1985 Dec; 72(6 Pt 2):V65-70. PubMed ID: 3905059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death.
    Fuster V; Steele PM; Chesebro JH
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):175B-184B. PubMed ID: 3889109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
    Chong BH
    Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspects of atherogenesis.
    Woolf N
    Br J Hosp Med; 1977 Oct; 18(4):286-7, 290-2. PubMed ID: 912151
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
    Chesebro JH; Fuster V
    Int J Cardiol; 1983; 2(5-6):511-6. PubMed ID: 6341260
    [No Abstract]   [Full Text] [Related]  

  • 38. Collagens in atherosclerosis.
    Barnes MJ
    Coll Relat Res; 1985 Jan; 5(1):65-97. PubMed ID: 3884248
    [No Abstract]   [Full Text] [Related]  

  • 39. The pathogenesis of atherosclerosis (first of two parts).
    Ross R; Glomset JA
    N Engl J Med; 1976 Aug; 295(7):369-77. PubMed ID: 819830
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of fluid dynamic factors in the development and progression of atherosclerosis, thrombosis and aneurysms].
    Goldsmith HL; Karino T
    Vasa Suppl; 1991; 32():14-7. PubMed ID: 1771483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.